biocon biologics - Robuta Search

https://bioconbiologicseu.com/biocon-biologics-moves-into-new-north-american-headquarters-in-bridgewater-new-jersey/ Biocon Biologics Moves into New North American Headquarters in Bridgewater, New Jersey - Aug 19, 2025 - Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company, today announced that the company has established its first North American... biocon biologics new north moves https://www.indianpharmapost.com/drug-approval/biocon-biologics-and-viatris-receive-approval-for-first-interchangeable-biosimilar-semglee-9985 Biocon Biologics and Viatris receive approval for first interchangeable biosimilar Semglee The company is eligible for 12 months exclusivity from launch biocon biologics viatris receive https://www.bioconbiologics.com/biocon-biologics-takes-forward-its-mission-to-unlock-universal-access-to-insulins-globally/ Biocon Biologics Takes Forward Its Mission to Unlock Universal Access to Insulins Globally - Biocon... biocon biologics https://manufacturing.economictimes.indiatimes.com/news/life-sciences/biocon-biologics-gets-ema-nod-to-manufacture-cancer-drug-in-india/111221933 Biocon Biologics gets EMA nod to manufacture cancer drug in India, ETManufacturing Cancer Drug In India: The company, in a statement, said that the biosimilar Bevacizumab will be manufactured at its new multi-product monoclonal antibodies... biocon biologics https://www.expresspharma.in/biocon-biologics-promotes-shreehas-tambe-to-deputy-chief-executive-officer/ Biocon Biologics promotes Shreehas Tambe to deputy chief executive officer - Express Pharma Mar 1, 2021 - Biocon Biologics announced that Shreehas Tambe has been promoted to the position of Deputy Chief Executive Officer of Biocon Biologics w.e.f. March 1, 2021. A... chief executive officer biocon biologics https://bioconbiologicseu.com/fi/transparency/ Biocon Biologics | Advancing Biosimilars for a Healthier and Affordable Future Dec 2, 2025 - Biocon Biologics is a leading global player in the development, manufacturing and commercialization of biosimilars. Our cutting-edge science, extensive... biocon biologics for a advancing biosimilars healthier https://www.medicaldesignsourcing.com/fda-approves-insulin-glargine-biosimilar-injection-from-viatris-biocon-biologics/ FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics - Medical Design... Jul 29, 2021 - Viatris (NSDQ:VTRS) and Biocon Biologics announced FDA clearance for their Semglee insulin glargine-yfgn injection as a biosimilar. Semglee holds indication... insulin glargine https://www.bioconbiologics.com/product-locator/bahrain/ Bahrain - Biocon Biologics bahrain biocon biologics https://biznextindia.com/companies/biocon-biologics-out-licenses-two-biosimilar-assets-to-yoshindo-for-commercialization-in-japan/ Biocon Biologics Out-Licenses Two Biosimilar Assets to Yoshindo for Commercialization in Japan -... Oct 17, 2022 - Bengaluru : Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), announced today, that it has entered into a strategic... https://www.bioconbiologics.com/about-us/our-work-in-biosimilars/ Our work in Biosimilars - Biocon Biologics Jun 20, 2025 - Biocon Biologics has one of the largest global biosimilars portfolios spanning recombinant human Insulin (rh-Insulin), insulin analogs... our work biosimilars biocon biologics https://ipverse.greyb.com/ptab-web/cases/case-details/PGR2026-00039 Biocon Biologics Limited et al. v. Regeneron Pharmaceuticals, Inc. - PGR2026-00039 - IP Verse Explore the PTAB proceeding PGR2026-00039 filed by Biocon Biologics Limited et al. against Regeneron Pharmaceuticals, Inc. on Apr 2, 2026. This includes filing... regeneron pharmaceuticals inc